← Back to Clinical Trials
Recruiting NCT06750601

NCT06750601 Rehablines: a Further Use Databank to (re)Use Routine Clinical Data for Scientific Research in Rehabilitation of People With Physical Disabilities and/or Chronic Diseases

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06750601
Status Recruiting
Phase
Sponsor University Medical Center Groningen
Condition Rehabilitation
Study Type OBSERVATIONAL
Enrollment 20,000 participants
Start Date 2023-08-01
Primary Completion 2044-01

Eligibility & Interventions

Sex All sexes
Min Age N/A
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 20,000 participants in total. It began in 2023-08-01 with a primary completion date of 2044-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Within the Center of Rehabilitation multidisciplinary treatment is provided to people with various physical disabilities and/or chronic diseases. During and in the context of this treatment, a lot of data is routinely collected. Rehablines is initiated to re-use this routine clinical data in a database for future scientific research. Rehablines aims to: - Efficiently conduct high quality scientific research aimed at patient characteristics, underlying disease processes, and treatment effects; - Provide insight into (short and long-term) treatment effects and efficiency of these rehabilitation treatments; - Personalize treatment by comparing data from the individual patient with data from a large number of patients with similar characteristics from Rehablines.

Eligibility Criteria

Inclusion Criteria: * all participants receiving care at the Center for Rehabilitation of the University Medical Center Groningen Exclusion Criteria: * n.a.

Contact & Investigator

Central Contact

K van Kammen, PhD, PhD

✉ rehablines@umcg.nl

📞 +3150 - 361 6160

Frequently Asked Questions

Who can join the NCT06750601 clinical trial?

This trial is open to participants of all sexes, studying Rehabilitation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06750601 currently recruiting?

Yes, NCT06750601 is actively recruiting participants. Contact the research team at rehablines@umcg.nl for enrollment information.

Where is the NCT06750601 trial being conducted?

This trial is being conducted at Groningen, Netherlands.

Who is sponsoring the NCT06750601 clinical trial?

NCT06750601 is sponsored by University Medical Center Groningen. The trial plans to enroll 20,000 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology